nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—Tacrolimus—atopic dermatitis	0.159	0.207	CbGbCtD
MACITENTAN—CYP3A4—Pimecrolimus—atopic dermatitis	0.0839	0.109	CbGbCtD
MACITENTAN—CYP2C19—Loratadine—atopic dermatitis	0.0755	0.0983	CbGbCtD
MACITENTAN—CYP2C19—Diphenhydramine—atopic dermatitis	0.0755	0.0983	CbGbCtD
MACITENTAN—ALB—Prednisone—atopic dermatitis	0.0645	0.084	CbGbCtD
MACITENTAN—CYP3A4—Tacrolimus—atopic dermatitis	0.0499	0.0649	CbGbCtD
MACITENTAN—CYP2C19—Prednisone—atopic dermatitis	0.0418	0.0545	CbGbCtD
MACITENTAN—CYP3A4—Loratadine—atopic dermatitis	0.0365	0.0475	CbGbCtD
MACITENTAN—CYP3A4—Methylprednisolone—atopic dermatitis	0.0334	0.0435	CbGbCtD
MACITENTAN—CYP2C19—Dexamethasone—atopic dermatitis	0.0261	0.034	CbGbCtD
MACITENTAN—CYP3A4—Triamcinolone—atopic dermatitis	0.0253	0.0329	CbGbCtD
MACITENTAN—CYP3A4—Betamethasone—atopic dermatitis	0.0217	0.0283	CbGbCtD
MACITENTAN—CYP3A4—Prednisolone—atopic dermatitis	0.0214	0.0279	CbGbCtD
MACITENTAN—CYP3A4—Hydrocortisone—atopic dermatitis	0.0203	0.0264	CbGbCtD
MACITENTAN—CYP3A4—Prednisone—atopic dermatitis	0.0202	0.0263	CbGbCtD
MACITENTAN—CYP3A4—Dexamethasone—atopic dermatitis	0.0126	0.0164	CbGbCtD
MACITENTAN—Infestation—Desonide—atopic dermatitis	0.00359	0.0277	CcSEcCtD
MACITENTAN—Infestation NOS—Desonide—atopic dermatitis	0.00359	0.0277	CcSEcCtD
MACITENTAN—Nasopharyngitis—Fluocinonide—atopic dermatitis	0.00337	0.026	CcSEcCtD
MACITENTAN—Pharyngitis—Desonide—atopic dermatitis	0.0032	0.0247	CcSEcCtD
MACITENTAN—Hepatotoxicity—Tacrolimus—atopic dermatitis	0.00319	0.0246	CcSEcCtD
MACITENTAN—Nasopharyngitis—Pimecrolimus—atopic dermatitis	0.00294	0.0227	CcSEcCtD
MACITENTAN—Influenza—Pimecrolimus—atopic dermatitis	0.00284	0.0219	CcSEcCtD
MACITENTAN—Bronchitis—Pimecrolimus—atopic dermatitis	0.00273	0.0211	CcSEcCtD
MACITENTAN—Infestation NOS—Pimecrolimus—atopic dermatitis	0.00253	0.0196	CcSEcCtD
MACITENTAN—Infestation—Pimecrolimus—atopic dermatitis	0.00253	0.0196	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—CCR3—atopic dermatitis	0.00251	0.0245	CbGpPWpGaD
MACITENTAN—Fluid retention—Tacrolimus—atopic dermatitis	0.00234	0.0181	CcSEcCtD
MACITENTAN—Infection—Desonide—atopic dermatitis	0.00227	0.0176	CcSEcCtD
MACITENTAN—Pharyngitis—Pimecrolimus—atopic dermatitis	0.00226	0.0174	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00225	0.0219	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Desonide—atopic dermatitis	0.00224	0.0173	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—CXCR3—atopic dermatitis	0.0022	0.0214	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Fluocinolone Acetonide—atopic dermatitis	0.00211	0.0163	CcSEcCtD
MACITENTAN—Influenza—Fluocinolone Acetonide—atopic dermatitis	0.00203	0.0157	CcSEcCtD
MACITENTAN—Nasopharyngitis—Mometasone—atopic dermatitis	0.00201	0.0155	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00201	0.0195	CbGpPWpGaD
MACITENTAN—Influenza—Mometasone—atopic dermatitis	0.00194	0.015	CcSEcCtD
MACITENTAN—Bronchitis—Mometasone—atopic dermatitis	0.00187	0.0144	CcSEcCtD
MACITENTAN—Infection—Fluocinonide—atopic dermatitis	0.00184	0.0142	CcSEcCtD
MACITENTAN—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00182	0.014	CcSEcCtD
MACITENTAN—Infestation NOS—Fluocinolone Acetonide—atopic dermatitis	0.00181	0.014	CcSEcCtD
MACITENTAN—Infestation—Fluocinolone Acetonide—atopic dermatitis	0.00181	0.014	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.0018	0.0175	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—CCR3—atopic dermatitis	0.0018	0.0175	CbGpPWpGaD
MACITENTAN—Pharyngitis—Loratadine—atopic dermatitis	0.0018	0.0139	CcSEcCtD
MACITENTAN—Urinary tract infection—Mometasone—atopic dermatitis	0.00168	0.013	CcSEcCtD
MACITENTAN—Oedema—Pimecrolimus—atopic dermatitis	0.00162	0.0125	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00161	0.0157	CbGpPWpGaD
MACITENTAN—Infection—Pimecrolimus—atopic dermatitis	0.00161	0.0124	CcSEcCtD
MACITENTAN—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00159	0.0122	CcSEcCtD
MACITENTAN—EDNRA—Peptide GPCRs—CXCR3—atopic dermatitis	0.00157	0.0153	CbGpPWpGaD
MACITENTAN—Hypotension—Dimenhydrinate—atopic dermatitis	0.00156	0.0121	CcSEcCtD
MACITENTAN—Hypotension—Diphenhydramine—atopic dermatitis	0.00156	0.0121	CcSEcCtD
MACITENTAN—Influenza—Tacrolimus—atopic dermatitis	0.00155	0.0119	CcSEcCtD
MACITENTAN—Pharyngitis—Mometasone—atopic dermatitis	0.00154	0.0119	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00151	0.0147	CbGpPWpGaD
MACITENTAN—Fluid retention—Prednisolone—atopic dermatitis	0.00149	0.0115	CcSEcCtD
MACITENTAN—Bronchitis—Tacrolimus—atopic dermatitis	0.00149	0.0115	CcSEcCtD
MACITENTAN—Fluid retention—Hydrocortisone—atopic dermatitis	0.00146	0.0113	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00145	0.0141	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00144	0.014	CbGpPWpGaD
MACITENTAN—Headache—Desonide—atopic dermatitis	0.00143	0.0111	CcSEcCtD
MACITENTAN—Infestation NOS—Tacrolimus—atopic dermatitis	0.00138	0.0106	CcSEcCtD
MACITENTAN—Infestation—Tacrolimus—atopic dermatitis	0.00138	0.0106	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—CCR5—atopic dermatitis	0.00138	0.0134	CbGpPWpGaD
MACITENTAN—Fluid retention—Triamcinolone—atopic dermatitis	0.00137	0.0106	CcSEcCtD
MACITENTAN—Fluid retention—Methylprednisolone—atopic dermatitis	0.00137	0.0106	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00135	0.0131	CbGpPWpGaD
MACITENTAN—Urinary tract infection—Tacrolimus—atopic dermatitis	0.00134	0.0103	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Other—CXCR3—atopic dermatitis	0.00133	0.013	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00129	0.0125	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Loratadine—atopic dermatitis	0.00126	0.00975	CcSEcCtD
MACITENTAN—Fluid retention—Betamethasone—atopic dermatitis	0.00125	0.00963	CcSEcCtD
MACITENTAN—Fluid retention—Dexamethasone—atopic dermatitis	0.00125	0.00963	CcSEcCtD
MACITENTAN—Pharyngitis—Tacrolimus—atopic dermatitis	0.00123	0.00949	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00121	0.0118	CbGpPWpGaD
MACITENTAN—Hypotension—Loratadine—atopic dermatitis	0.0012	0.00929	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00118	0.0115	CbGpPWpGaD
MACITENTAN—Headache—Fluocinonide—atopic dermatitis	0.00116	0.00897	CcSEcCtD
MACITENTAN—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.00116	0.00894	CcSEcCtD
MACITENTAN—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00115	0.00888	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—CCL22—atopic dermatitis	0.00115	0.0112	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00113	0.00876	CcSEcCtD
MACITENTAN—Angiopathy—Tacrolimus—atopic dermatitis	0.00112	0.00867	CcSEcCtD
MACITENTAN—Infection—Mometasone—atopic dermatitis	0.0011	0.00848	CcSEcCtD
MACITENTAN—Fluid retention—Prednisone—atopic dermatitis	0.00109	0.00839	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00108	0.0105	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—NPS—atopic dermatitis	0.00107	0.0104	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00107	0.0104	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00105	0.0103	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00105	0.0103	CbGpPWpGaD
MACITENTAN—Headache—Diphenhydramine—atopic dermatitis	0.00105	0.00809	CcSEcCtD
MACITENTAN—Headache—Dimenhydrinate—atopic dermatitis	0.00105	0.00809	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00104	0.0101	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00103	0.0101	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL27—atopic dermatitis	0.00102	0.00998	CbGpPWpGaD
MACITENTAN—Headache—Pimecrolimus—atopic dermatitis	0.00101	0.00782	CcSEcCtD
MACITENTAN—Anaemia—Tacrolimus—atopic dermatitis	0.000996	0.00769	CcSEcCtD
MACITENTAN—EDNRA—Peptide GPCRs—CCR5—atopic dermatitis	0.000986	0.0096	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000973	0.00948	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000963	0.00938	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000954	0.0093	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000954	0.0093	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000925	0.00902	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL17—atopic dermatitis	0.000919	0.00895	CbGpPWpGaD
MACITENTAN—Influenza—Triamcinolone—atopic dermatitis	0.000908	0.00701	CcSEcCtD
MACITENTAN—Oedema—Tacrolimus—atopic dermatitis	0.000879	0.00679	CcSEcCtD
MACITENTAN—Infection—Tacrolimus—atopic dermatitis	0.000874	0.00675	CcSEcCtD
MACITENTAN—Bronchitis—Triamcinolone—atopic dermatitis	0.000874	0.00675	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000864	0.00841	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000862	0.00666	CcSEcCtD
MACITENTAN—Infestation—Hydrocortisone—atopic dermatitis	0.00086	0.00664	CcSEcCtD
MACITENTAN—Infestation NOS—Hydrocortisone—atopic dermatitis	0.00086	0.00664	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000846	0.00824	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Other—CCR5—atopic dermatitis	0.000835	0.00814	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000835	0.00814	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—MAPK8—atopic dermatitis	0.000833	0.00812	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL22—atopic dermatitis	0.000823	0.00801	CbGpPWpGaD
MACITENTAN—Hypotension—Tacrolimus—atopic dermatitis	0.000822	0.00635	CcSEcCtD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000809	0.00788	CbGpPWpGaD
MACITENTAN—Infestation—Methylprednisolone—atopic dermatitis	0.000808	0.00624	CcSEcCtD
MACITENTAN—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000808	0.00624	CcSEcCtD
MACITENTAN—Headache—Loratadine—atopic dermatitis	0.000807	0.00623	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000793	0.00772	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000764	0.00744	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—NPS—atopic dermatitis	0.000764	0.00744	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000754	0.00735	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000754	0.00735	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL11—atopic dermatitis	0.000741	0.00722	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000739	0.0072	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL27—atopic dermatitis	0.000733	0.00714	CbGpPWpGaD
MACITENTAN—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000725	0.0056	CcSEcCtD
MACITENTAN—Pharyngitis—Triamcinolone—atopic dermatitis	0.000722	0.00557	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000719	0.007	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000707	0.00688	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000707	0.00688	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000696	0.00678	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000693	0.00675	CbGpPWpGaD
MACITENTAN—Headache—Mometasone—atopic dermatitis	0.000692	0.00534	CcSEcCtD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000683	0.00665	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000683	0.00665	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000662	0.00645	CbGpPWpGaD
MACITENTAN—Angiopathy—Methylprednisolone—atopic dermatitis	0.000658	0.00508	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—CCL17—atopic dermatitis	0.000658	0.00641	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000648	0.00631	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCR3—atopic dermatitis	0.000604	0.00588	CbGpPWpGaD
MACITENTAN—Angiopathy—Dexamethasone—atopic dermatitis	0.000599	0.00462	CcSEcCtD
MACITENTAN—Angiopathy—Betamethasone—atopic dermatitis	0.000599	0.00462	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000598	0.00582	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—MAPK8—atopic dermatitis	0.000596	0.00581	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL22—atopic dermatitis	0.00059	0.00575	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCL27—atopic dermatitis	0.000579	0.00564	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000579	0.00564	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000567	0.00553	CbGpPWpGaD
MACITENTAN—Oedema—Prednisolone—atopic dermatitis	0.000562	0.00434	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00056	0.00546	CbGpPWpGaD
MACITENTAN—Headache—Tacrolimus—atopic dermatitis	0.000551	0.00425	CcSEcCtD
MACITENTAN—Oedema—Hydrocortisone—atopic dermatitis	0.000549	0.00424	CcSEcCtD
MACITENTAN—Infection—Hydrocortisone—atopic dermatitis	0.000545	0.00421	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—NPS—atopic dermatitis	0.000538	0.00524	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—TAC1—atopic dermatitis	0.000538	0.00524	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000538	0.00415	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—CCL11—atopic dermatitis	0.00053	0.00516	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCR3—atopic dermatitis	0.000528	0.00514	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL27—atopic dermatitis	0.000526	0.00512	CbGpPWpGaD
MACITENTAN—Angiopathy—Prednisone—atopic dermatitis	0.000521	0.00403	CcSEcCtD
MACITENTAN—Oedema—Triamcinolone—atopic dermatitis	0.000517	0.00399	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000515	0.00501	CbGpPWpGaD
MACITENTAN—Infection—Triamcinolone—atopic dermatitis	0.000513	0.00396	CcSEcCtD
MACITENTAN—Hypotension—Hydrocortisone—atopic dermatitis	0.000513	0.00396	CcSEcCtD
MACITENTAN—Infection—Methylprednisolone—atopic dermatitis	0.000512	0.00395	CcSEcCtD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000507	0.00494	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000506	0.00493	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000506	0.00493	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000505	0.0039	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000496	0.00483	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000482	0.0047	CbGpPWpGaD
MACITENTAN—Hypotension—Methylprednisolone—atopic dermatitis	0.000482	0.00372	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—CCL17—atopic dermatitis	0.000472	0.00459	CbGpPWpGaD
MACITENTAN—Oedema—Betamethasone—atopic dermatitis	0.000469	0.00362	CcSEcCtD
MACITENTAN—Oedema—Dexamethasone—atopic dermatitis	0.000469	0.00362	CcSEcCtD
MACITENTAN—Infection—Dexamethasone—atopic dermatitis	0.000466	0.0036	CcSEcCtD
MACITENTAN—Infection—Betamethasone—atopic dermatitis	0.000466	0.0036	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000464	0.00452	CbGpPWpGaD
MACITENTAN—Anaemia—Prednisone—atopic dermatitis	0.000462	0.00357	CcSEcCtD
MACITENTAN—Nervous system disorder—Betamethasone—atopic dermatitis	0.00046	0.00355	CcSEcCtD
MACITENTAN—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00046	0.00355	CcSEcCtD
MACITENTAN—Hypotension—Betamethasone—atopic dermatitis	0.000438	0.00338	CcSEcCtD
MACITENTAN—Hypotension—Dexamethasone—atopic dermatitis	0.000438	0.00338	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000434	0.00423	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCR3—atopic dermatitis	0.000432	0.00421	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCL10—atopic dermatitis	0.000427	0.00416	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL22—atopic dermatitis	0.000422	0.00411	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCL27—atopic dermatitis	0.000414	0.00404	CbGpPWpGaD
MACITENTAN—Oedema—Prednisone—atopic dermatitis	0.000408	0.00315	CcSEcCtD
MACITENTAN—Infection—Prednisone—atopic dermatitis	0.000405	0.00313	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000401	0.00391	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Prednisone—atopic dermatitis	0.0004	0.00309	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000392	0.00381	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.000387	0.00377	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—NPS—atopic dermatitis	0.000385	0.00375	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—TAC1—atopic dermatitis	0.000385	0.00375	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL11—atopic dermatitis	0.00038	0.0037	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCR3—atopic dermatitis	0.000378	0.00368	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL27—atopic dermatitis	0.000376	0.00367	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—FCER2—atopic dermatitis	0.000375	0.00365	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL5—atopic dermatitis	0.000367	0.00358	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000363	0.00354	CbGpPWpGaD
MACITENTAN—Headache—Prednisolone—atopic dermatitis	0.000352	0.00272	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—CCL22—atopic dermatitis	0.000348	0.00339	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000345	0.00336	CbGpPWpGaD
MACITENTAN—Headache—Hydrocortisone—atopic dermatitis	0.000344	0.00265	CcSEcCtD
MACITENTAN—EDNRB—GPCR downstream signaling—CCR3—atopic dermatitis	0.000341	0.00332	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL17—atopic dermatitis	0.000337	0.00329	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCR5—atopic dermatitis	0.000331	0.00322	CbGpPWpGaD
MACITENTAN—Headache—Triamcinolone—atopic dermatitis	0.000324	0.0025	CcSEcCtD
MACITENTAN—Headache—Methylprednisolone—atopic dermatitis	0.000323	0.00249	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000311	0.00303	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL27—atopic dermatitis	0.000311	0.00303	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCR3—atopic dermatitis	0.00031	0.00302	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL4—atopic dermatitis	0.000305	0.00297	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL10—atopic dermatitis	0.000305	0.00297	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—NPS—atopic dermatitis	0.000304	0.00296	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—TAC1—atopic dermatitis	0.000304	0.00296	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000298	0.00291	CbGpPWpGaD
MACITENTAN—Headache—Betamethasone—atopic dermatitis	0.000294	0.00227	CcSEcCtD
MACITENTAN—Headache—Dexamethasone—atopic dermatitis	0.000294	0.00227	CcSEcCtD
MACITENTAN—EDNRB—GPCR downstream signaling—IL5—atopic dermatitis	0.000283	0.00275	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00028	0.00273	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL17—atopic dermatitis	0.000279	0.00271	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—TAC1—atopic dermatitis	0.000276	0.00269	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—NPS—atopic dermatitis	0.000276	0.00269	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL11—atopic dermatitis	0.000272	0.00265	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCR3—atopic dermatitis	0.000271	0.00264	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FCER2—atopic dermatitis	0.000268	0.00261	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL5—atopic dermatitis	0.000263	0.00256	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000263	0.00256	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00026	0.00253	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL5—atopic dermatitis	0.000257	0.0025	CbGpPWpGaD
MACITENTAN—Headache—Prednisone—atopic dermatitis	0.000256	0.00197	CcSEcCtD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00025	0.00243	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL22—atopic dermatitis	0.000249	0.00243	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KIF3A—atopic dermatitis	0.000248	0.00242	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR3—atopic dermatitis	0.000244	0.00238	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000241	0.00235	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCR5—atopic dermatitis	0.000237	0.00231	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000227	0.00221	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL11—atopic dermatitis	0.000225	0.00219	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CMA1—atopic dermatitis	0.000225	0.00219	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL27—atopic dermatitis	0.000222	0.00217	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR3—atopic dermatitis	0.000222	0.00216	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL10—atopic dermatitis	0.000219	0.00213	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—NPS—atopic dermatitis	0.000218	0.00212	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—TAC1—atopic dermatitis	0.000218	0.00212	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000213	0.00208	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STAT6—atopic dermatitis	0.000211	0.00206	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCL5—atopic dermatitis	0.000208	0.00202	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000202	0.00197	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL5—atopic dermatitis	0.000202	0.00197	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCL8—atopic dermatitis	0.0002	0.00195	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL17—atopic dermatitis	0.000199	0.00194	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000199	0.00194	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—TAC1—atopic dermatitis	0.000198	0.00193	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—NPS—atopic dermatitis	0.000198	0.00193	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCR3—atopic dermatitis	0.000194	0.00189	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL5—atopic dermatitis	0.000188	0.00184	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000188	0.00183	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000188	0.00183	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCR5—atopic dermatitis	0.000187	0.00182	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IFNG—atopic dermatitis	0.000185	0.0018	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL5—atopic dermatitis	0.000184	0.00179	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR3—atopic dermatitis	0.000183	0.00178	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KIF3A—atopic dermatitis	0.000178	0.00173	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000173	0.00168	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCR5—atopic dermatitis	0.00017	0.00165	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL1B—atopic dermatitis	0.000165	0.0016	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL2—atopic dermatitis	0.000164	0.0016	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000163	0.00159	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NPS—atopic dermatitis	0.000163	0.00159	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TAC1—atopic dermatitis	0.000163	0.00159	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CMA1—atopic dermatitis	0.000161	0.00157	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL11—atopic dermatitis	0.000161	0.00157	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCR3—atopic dermatitis	0.00016	0.00156	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL10—atopic dermatitis	0.000157	0.00153	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL5—atopic dermatitis	0.000152	0.00148	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—STAT6—atopic dermatitis	0.000151	0.00147	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00015	0.00146	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCL5—atopic dermatitis	0.000149	0.00145	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000147	0.00143	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000147	0.00143	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL8—atopic dermatitis	0.000143	0.00139	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000143	0.00139	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KIF3A—atopic dermatitis	0.000138	0.00134	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL5—atopic dermatitis	0.000135	0.00131	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000134	0.00131	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR5—atopic dermatitis	0.000134	0.0013	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR3—atopic dermatitis	0.000131	0.00128	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000131	0.00127	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL10—atopic dermatitis	0.000129	0.00126	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR5—atopic dermatitis	0.000122	0.00118	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—atopic dermatitis	0.000119	0.00116	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000118	0.00115	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TAC1—atopic dermatitis	0.000117	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NPS—atopic dermatitis	0.000117	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCR3—atopic dermatitis	0.000115	0.00112	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000113	0.0011	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL5—atopic dermatitis	0.000111	0.00108	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SELE—atopic dermatitis	0.000111	0.00108	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL5—atopic dermatitis	0.000109	0.00106	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2—atopic dermatitis	0.000108	0.00105	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NGF—atopic dermatitis	0.000103	0.001	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL8—atopic dermatitis	0.000103	0.001	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR5—atopic dermatitis	0.0001	0.000977	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL2—atopic dermatitis	9.81e-05	0.000956	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—atopic dermatitis	9.64e-05	0.000939	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	9.53e-05	0.000929	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	9.49e-05	0.000925	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL10—atopic dermatitis	9.26e-05	0.000902	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NFKBIA—atopic dermatitis	8.5e-05	0.000828	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL5—atopic dermatitis	8.42e-05	0.00082	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL8—atopic dermatitis	8.09e-05	0.000788	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL5—atopic dermatitis	7.97e-05	0.000776	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2—atopic dermatitis	7.73e-05	0.000753	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	7.66e-05	0.000746	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NGF—atopic dermatitis	7.38e-05	0.000719	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL8—atopic dermatitis	7.35e-05	0.000716	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR5—atopic dermatitis	7.18e-05	0.000699	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—atopic dermatitis	7.02e-05	0.000684	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GLB1—atopic dermatitis	6.67e-05	0.000649	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ADSL—atopic dermatitis	6.39e-05	0.000623	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	6.24e-05	0.000608	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NFKBIA—atopic dermatitis	6.09e-05	0.000593	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL8—atopic dermatitis	6.06e-05	0.000591	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GLB1—atopic dermatitis	5.98e-05	0.000583	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—atopic dermatitis	5.79e-05	0.000565	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—atopic dermatitis	5.77e-05	0.000562	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ADSL—atopic dermatitis	5.74e-05	0.000559	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK8—atopic dermatitis	5.33e-05	0.00052	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.86e-05	0.000473	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.62e-05	0.00045	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.36e-05	0.000425	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL8—atopic dermatitis	4.34e-05	0.000423	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—atopic dermatitis	4.15e-05	0.000404	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—atopic dermatitis	4.13e-05	0.000402	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK8—atopic dermatitis	3.82e-05	0.000372	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.6e-05	0.000351	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.45e-05	0.000336	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—atopic dermatitis	3.41e-05	0.000332	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—atopic dermatitis	3.22e-05	0.000313	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—atopic dermatitis	2.44e-05	0.000237	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARA—atopic dermatitis	2.16e-05	0.000211	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.94e-05	0.000189	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.17e-05	0.000114	CbGpPWpGaD
